Savitz Ryan
5 of 34 shown
The 5 most recent of 34 visible filings, newest first.
- Dianthus Therapeutics, Inc. /DE/ EVP, CFO & CBO16,385 sharesOption exercise
- Dianthus Therapeutics, Inc. /DE/ EVP, CFO & CBO1,339 sharesOption exercise
- Dianthus Therapeutics, Inc. /DE/ EVP, CFO & CBO$1,605,085Open-market sale
- Dianthus Therapeutics, Inc. /DE/ EVP, CFO & CBO$361,617Option exercise
- Dianthus Therapeutics, Inc. /DE/ EVP, CFO & CBO$29,150Option exercise